NIAMS UG3/UH3 Clinical Trial Implementation Cooperative Agreement
NIAMS is soliciting applications for a two-phase, milestone-driven UG3 (start-up) / UH3 (implementation) cooperative agreement to support NIH-defined clinical trials addressing arthritis, musculoskeletal, and skin diseases. The UG3 (up to 1 year) funds final start-up activities—sIRB setup, site contracts, DSMB approval, project management plans, and regulatory approvals—and transition to the U…
Clinical research is a significant NIAMS investment aimed at answering critical questions about a particular disease or disease process. It is essential to support clinical trial studies to test promising new interventions with the potential to improve health and impact clinical care. NIAMS is c…
Funding Source
Eligibility
Foreign/Non-domestic applicant eligibility: Non-domestic (non-U.S.) entities (foreign organizations) are NOT eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are NOT eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed in ap…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers